M
MRNA
Productby Moderna, Inc.
Heard in 6 episodes across 2 shows since Aug 2026
The Nasdaq stock ticker for Moderna, Inc., a biotechnology company focused on mRNA-based medicines and vaccines.
Episodes
6
across 2 shows
First heard
Aug 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
3
3
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 3 |
| Sep 2026 | 3 |
| Oct 2026 | 0 |
Episodes
6 episodes featuring MRNA, newest first
- Sep 25, 2026
Three stocks expose AI fervor, deal risk and biotech promiseStock MoversSep 25, 2026 - Sep 22, 2026
Shopify, Moderna and On ride distinct catalystsStock MoversSep 22, 2026 - Sep 3, 2026
AI spending strains markets as growth investors rethink riskEquity Mates Investing PodcastSep 3, 2026 - Aug 20, 2026
Earnings winners collide with Moderna’s record reversalStock MoversAug 20, 2026 - Aug 19, 2026
Moderna advances cancer vaccine as rail merger review resumesStock MoversAug 19, 2026 - Aug 19, 2026
Moderna rallies as buybacks and turnarounds test marketsStock MoversAug 19, 2026